Concepedia

Gabriele Luppi

GL

62

Publications

6.1K

Citations

31

H-Index

1994

Active since

Affiliations

University of Modena and Reggio Emilia(Current)

Azienda Ospedaliero-Universitaria di Modena

Istituto Oncologico Veneto

Azienda Ospedaliero-Universitaria Careggi

Istituti di Ricovero e Cura a Carattere Scientifico

Gabriele Luppi is an author at University of Modena and Reggio Emilia specializing in oncology, radiation oncology, and medicine.

ORCID

Top concepts

Publications per year

1994–2023

62

Publications

62

EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer

Alberto Sobrero, Joan Maurel, Louis Fehrenbacher et al. · Journal of Clinical Oncology · 2008 · 945 citations · Full text

Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial

C. Aschele, L. Cionini, Sara Lonardi et al. · Journal of Clinical Oncology · 2011 · 762 citations · Full text

Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial

James C. Yao, Catherine Lombard‐Bohas, Éric Baudin et al. · Journal of Clinical Oncology · 2009 · 648 citations · Full text

, , +15

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

Cathy Eng, Tae Won Kim, Johanna C. Bendell et al. · The Lancet Oncology · 2019 · 543 citations · Full text

, , +10

Epidermal Growth Factor Receptor Gene Copy Number and Clinical Outcome of Metastatic Colorectal Cancer Treated With Panitumumab

Andrea Sartore‐Bianchi, Mauro Moroni, Silvio Veronese et al. · Journal of Clinical Oncology · 2007 · 337 citations · Full text

Rows per page

1–5 of 62